Preparation and application of polyvinyl alcohol‐decorated cell membrane chromatography for screening anti‐osteoporosis components from Liuwei Dihuang decoction‐containing serum. Issue 11 (29th March 2020)

• Record Type: Journal Article
• Authors: Wu, Can; Wang, Nani; Xu, Pingcui; Wang, Xuping; Shou, Dan; Zhu, Yan
• Is Part Of: Journal of separation science. Volume 43:Issue 11(2020)
• Page Start: 2105
• Page End: 2114
• Publication Date: 2020-03-29
• Subjects: osteoblast cell membrane chromatography -- polyvinyl alcohol‐decorated -- metabolites -- rat serum -- traditional Chinese medicine; Separation (Technology) -- Periodicals; Chromatographic analysis -- Periodicals; 543.089
• DOI: 10.1002/jssc.201901203
• Languages: English
• ISSNs: 1615-9306

Abstract

Abstract: Cell membrane chromatography is a powerful tool for screening active components from complex matrices. New cell membrane carriers need to be developed to increase the coverage of cell membranes on the surface of stationary phases, thereby improving cell membrane chromatographic retention. In this work, we prepared polyvinyl alcohol‐poly dimethyl diallyl ammonium chloride modified silica gel as a cell membrane carrier. Osteoblast cell was used as cell membrane source, which was widely used to evaluate the osteogenic activity of drugs. The new cell membrane chromatographic stationary phase was used to screen anti‐osteoporosis components in Liuwei Dihuang decoction‐containing serum. The chemical structures of the new modified materials were characterized by scanning electronic microscopy, Fourier transform infrared spectroscopy, and elemental analysis characterization. Compared with the common cell membrane column, the cell membrane coverage of this modified material was increased by 30%, and thus provided a stronger retention effect in positive drugs. Nineteen metabolites in rat serum samples were retained on the cell membrane chromatography and identified by ultra‐high‐performance liquid chromatography/time‐of‐flight mass spectrometry. Among those, four components (morroniside, catalpol, loganin, and acteoside) were selected for in vitro pharmacodynamics validation. They significantly increased the osteoblast proliferation. The new modified material was successfully applied to screen anti‐osteoporosis components from Liuwei Dihuang Decoction‐containing serum.